Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Jun 7, 2025; 31(21): 107029
Published online Jun 7, 2025. doi: 10.3748/wjg.v31.i21.107029
Figure 1
Figure 1 Kaplan–Meier survival analysis after propensity score matching. A: Moderately differentiated gastric cancer (GC) patients 3 years postoperatively log odds of positive lymph nodes (LODDS) 1 vs LODDS2; B: Moderately differentiated GC patients 3 years postoperatively N1 + N2 vs N3a + N3b; C: Moderately differentiated GC patients 3-5 years postoperatively LODDS1 vs LODDS2; D: Moderately differentiated GC patients 3-5 years postoperatively N1 + N2 vs N3a + N3b; E: Poorly differentiated GC patients 3 years postoperatively LODDS1 vs LODDS2; F: Poorly differentiated GC patients 3 years after surgery N1 + N2 vs N3a + N3b; G: Poorly differentiated GC patients 3-5 years after surgery LODDS1 vs LODDS2; H: Poorly differentiated GC patients 3-5 years after surgery N1 + N2 vs N3a + N3b. LODDS: Log odds of positive lymph nodes.